The European Journal of Immunology (EJI) is a basic immunology research journal, focusing on various aspects of immunology.
Conventional vaccines usually contain antigens—components of the respective pathogens—that bind to receptors on the surface of their target cells in order to trigger the disease. Scientists at the Berlin Institute of ...
Jul 25, 2023
0
1
Critically ill COVID-19 patients often have antibodies in their blood that bind to the body's own structures, so-called autoantibodies. Scientists from the BIH at Charité and the Max Delbrück Center have now discovered ...
Apr 4, 2023
0
17
Despite daily contact with COVID-19 patients early in the pandemic, some health professionals avoided falling ill. As a University of Gothenburg study shows, the explanation appears to be an antidote in the immune system: ...
Mar 24, 2022
0
63
When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies. A similar immune response is triggered by coronavirus vaccines. However, there is still little data available ...
Mar 18, 2022
0
7
Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection. The syndrome is rare, and it remains unclear how the viral infection leads to MIS-C and why it only ...
Oct 7, 2021
0
5
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade ...
Oct 23, 2020
0
45
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the ...
Dec 6, 2018
0
361
In autoimmune diseases such as type 1 diabetes, some of the immune system's T cells mistakenly attack the body's own cells, while protective T regulatory cells try to defend against that attack. Scientists at Joslin Diabetes ...
Apr 5, 2018
0
17
Antibody-based immunotherapy is a new promising method to treat cancer. Unfortunately, today's treatments can result in adverse side effects. New findings from IGP show an alternative way to administer the therapy, which ...
Dec 8, 2016
0
2
Natural killer cells of the immune system can fend off malignant lymphoma cells and thus are considered a promising therapeutic approach. However, in the direct vicinity of the tumor they lose their effect. Scientists of ...
Jul 8, 2015
0
9
